Globus Medical, Inc., a leading innovator in the musculoskeletal implant industry, is headquartered in the United States. Founded in 2003, the company has rapidly established itself as a key player in spinal surgery, focusing on the development of advanced surgical solutions and technologies. With a strong presence across North America and expanding operations in international markets, Globus Medical is dedicated to improving patient outcomes through its innovative products. The company’s core offerings include spinal fusion devices, minimally invasive surgical instruments, and biologics, all designed to enhance surgical efficiency and patient recovery. Globus Medical is recognised for its commitment to research and development, which has led to numerous industry accolades and a robust market position. With a focus on quality and innovation, Globus Medical continues to set new standards in the orthopaedic and spinal surgery sectors.
How does Globus Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Globus Medical, Inc.'s score of 26 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
As of the latest available data, Globus Medical, Inc. does not report any specific carbon emissions figures, indicating a lack of publicly disclosed emissions data. Consequently, there are no recorded Scope 1, 2, or 3 emissions figures to summarise. In terms of climate commitments, there are no documented reduction targets or initiatives outlined by the company. This absence of information suggests that Globus Medical, Inc. may not currently have formalised climate pledges or science-based targets in place. Given the context of the medical device industry, it is increasingly important for companies to establish and communicate their climate strategies, particularly as stakeholders and consumers are becoming more environmentally conscious. Without specific emissions data or reduction commitments, Globus Medical, Inc. may face challenges in demonstrating its environmental responsibility and sustainability efforts.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Globus Medical, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
